What is Scholar Rock's debt repayments?

Scholar Rock (SRRK) reported debt repayments of $103.06M in Q1 2026.

What does debt repayments mean?

Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.

Scholar Rock SRRK Debt Repayments

Debt Repayments at other companies

Cogent Biosciences, Inc.COGT

$13.66M—

BridgeBio PharmaBBIO

$0-100%

Arrowhead ResearchARWR

$17.83M-88.2%

CytokineticsCYTK

$2.74M+2.0%

Rhythm Pharmaceuticals, Inc.RYTM

$4.29M-7.1%

BrightSpring Health Services, Inc.BTSG

$12.35M+4.8%

Other financials

Income statement

See full

Revenue-—

Operating income-$102.0M-32.3%

Net income-$105.5M-41.2%

EPS (diluted)-$0.83-23.9%

Balance sheet

See full

Cash & equivalents$430.5M+212%

Total debt$205.7M+226%

Total equity$276.0M-11.6%

Total assets$535.3M+31.3%

Cash flow

See full

Operating cash flow-$82.1M-4.4%

CapEx$68.0K-74.9%

Free cash flow-$82.2M-4.1%

Valuation

See full

Market cap$5.67B+85.5%

Profitability

See full

Operating margin-231.8%—

Net margin-236.9%—

FCF margin-309.1%—

Returns & leverage

See full

Return on equity-138.9%+60.1pp

Debt / equity0.7×+0.5×

Current ratio8.6×-1.6×

Where this comes from

Reported directly by Scholar Rock in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfLongTermDebt.

The official record: Scholar Rock’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Scholar Rock's debt repayments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Scholar Rock's debt repayments?: Scholar Rock (SRRK) reported debt repayments of $103.06M in Q1 2026.
What does debt repayments mean?: Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.